Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

HC Wainwright Annual Global Investment Conference
 Monday, September 14, 2020
 12:00pm EDT